The Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, in cosponsorship with the Drug Information Association (DIA), is announcing a meeting entitled ``FDA/DIA Oligonucleotide-Based Therapeutics Conference 2015'' (FDA/DIA 2015 conference). The purpose of the meeting is to discuss advances, safety, and challenges in the field of oligonucleotide-based therapeutics.
Document
Food and Drug Administration/Drug Information Association Oligonucleotide-Based Therapeutics Conference 2015
The Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, in cosponsorship with the Drug Information Association (DIA), is announcing a meeting entitle...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 53162
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Food and Drug Administration/Drug Information Association Oligonucleotide-Based Therapeutics Conference 2015,” thefederalregister.org (September 2, 2015), https://thefederalregister.org/documents/2015-21639/food-and-drug-administration-drug-information-association-oligonucleotide-based-therapeutics-conference-2015.